|
|
||||||||
1 Department of Chemical and Environmental Engineering, University of California at Riverside, Riverside, California 92521-0444, USA
2 Department of Biochemistry, University of Iowa, Iowa City, Iowa 52242-1109, USA
3 Department of Chemistry and Biochemistry, University of California at San Diego, La Jolla, California 92093-0365, USA
4 Department of Pharmacology and Howard Hughes Medical Institute, University of California at San Diego, La Jolla, California 92093-0365, USA
Reprint requests to: Dr. Dimitrios Morikis, Department of Chemical and Environmental Engineering, University of California at Riverside, Riverside, CA 92521-0444, USA; e-mail: dmorikis{at}engr.ucr.edu; fax: (909) 787-2425.
Glycinamide ribonucleotide transformylase (GART) undergoes a pH-dependent coilhelix transition with pKa
7. An
-helix is formed at high pH spanning 8 residues of a 21-residue-long loop, comprising the segment Thr120His121Arg122Gln123Ala124Leu125Glu126Asn127. To understand the electrostatic nature of this loophelix, called the activation loophelix, which leads to the formation and stability of the
-helix, pKa values of all ionizable residues of GART have been calculated, using PoissonBoltzmann electrostatic calculations and crystallographic data. Crystallographic structures of high and low pH E70A GART have been used in our analysis. Low pKa values of 5.3, 5.3, 3.9, 1.7, and 4.7 have been calculated for five functionally important histidines, His108, His119, His121, His132, and His137, respectively, using the high pH E70A GART structure. Ten theoretical single and double mutants of the high pH E70A structure have been constructed to idey pairwise interactions of ionizable residues, which have aided in elucidating the multiplicity of electrostatic interactions of the activation loophelix, and the impact of the activation helix on the catalytic site. Based on our pKa calculations and structural data, we propose that: (1) His121 forms a molecular switch for the coilhelix transition of the activation helix, depending on its protonation state; (2) a strong electrostatic interaction between His132 and His121 is observed, which can be of stabilizing or destabilizing nature for the activation helix, depending on the relative orientation and protonation states of the rings of His121 and His132; (3) electrostatic interactions involving His119 and Arg122 play a role in the stability of the activation helix; and (4) the activation helix contains the helix-promoting sequence Arg122Gln123Ala124Leu125Glu126, but its alignment relative to the N and C termini of the helix is not optimal, and is possibly of a destabilizing nature. Finally, we provide electrostatic evidence that the formation and closure of the activation helix create a hydrophobic environment for catalytic-site residue His108, to facilitate catalysis.
Keywords: GART ; glycinamide ribonucleotide transformylase ; electrostatic calculations ; Poisson-Boltz-mann ; pKa ; helix-coil transition
Abbreviations: GAR, glycinamide ribonucleotide GART, GAR transformulase PDB, Protein Data Bank
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
G. Archontis and T. Simonson Proton Binding to Proteins: A Free-Energy Component Analysis Using a Dielectric Continuum Model Biophys. J., June 1, 2005; 88(6): 3888 - 3904. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Morikis and J. D. Lambris The Electrostatic Nature of C3d-Complement Receptor 2 Association J. Immunol., June 15, 2004; 172(12): 7537 - 7547. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Nielsen and J. A. McCammon On the evaluation and optimization of protein X-ray structures for pKa calculations Protein Sci., February 1, 2003; 12(2): 313 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Morikis, A. H. Elcock, P. A. Jennings, and J. A. McCammon Proton transfer dynamics of GART: The pH-dependent catalytic mechanism examined by electrostatic calculations Protein Sci., November 1, 2001; 10(11): 2379 - 2392. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |